Home
Drugging disordered
proteins the new way
Peptone is a biotechnology company creating novel
small-molecule therapeutics that selectively target
intrinsically disordered proteins (IDPs).
Embracing
protein
disorder
Many diseases result from changes in protein structure
that disrupt their function, yet several disease-related
proteins remain difficult to address.
Drugging
“invisible”
pockets
Peptone’s technology models
disordered proteins of any
size or complexity, providing
insights into small-molecule
druggable pockets.
- Bespoke
Mass Spectrometry - Next-Generation Machine Learning
- Protein Disorder
Laboratory Expertise